DE60236639D1 - Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust - Google Patents

Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust

Info

Publication number
DE60236639D1
DE60236639D1 DE60236639T DE60236639T DE60236639D1 DE 60236639 D1 DE60236639 D1 DE 60236639D1 DE 60236639 T DE60236639 T DE 60236639T DE 60236639 T DE60236639 T DE 60236639T DE 60236639 D1 DE60236639 D1 DE 60236639D1
Authority
DE
Germany
Prior art keywords
tinnitus
compositions
hearing loss
local treatment
new procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60236639T
Other languages
English (en)
Inventor
Helge Rask-Andersen
Johan Stjernschantz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synphora AB
Original Assignee
Synphora AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora AB filed Critical Synphora AB
Application granted granted Critical
Publication of DE60236639D1 publication Critical patent/DE60236639D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Fertilizers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60236639T 2001-01-19 2002-01-15 Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust Expired - Lifetime DE60236639D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100158A SE0100158D0 (sv) 2001-01-19 2001-01-19 Novel method and composition for local treatment of Meniere´s disease and tinnitus
PCT/SE2002/000062 WO2002056890A1 (en) 2001-01-19 2002-01-15 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss

Publications (1)

Publication Number Publication Date
DE60236639D1 true DE60236639D1 (de) 2010-07-22

Family

ID=20282672

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60236639T Expired - Lifetime DE60236639D1 (de) 2001-01-19 2002-01-15 Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust

Country Status (15)

Country Link
US (1) US7498360B2 (de)
EP (1) EP1351693B1 (de)
JP (2) JP4202135B2 (de)
CN (1) CN1307998C (de)
AT (1) ATE470446T1 (de)
AU (1) AU2002219765B2 (de)
BR (1) BR0206568A (de)
CA (1) CA2434272C (de)
DE (1) DE60236639D1 (de)
HK (1) HK1061975A1 (de)
MX (1) MXPA03006439A (de)
NZ (1) NZ526972A (de)
PL (1) PL362803A1 (de)
SE (1) SE0100158D0 (de)
WO (1) WO2002056890A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050171054A1 (en) * 2001-01-19 2005-08-04 Helge Rask-Andersen Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
AU2003301077B2 (en) * 2002-12-18 2009-12-24 Hough Ear Institute Otologic nanotechnology
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
KR20070028462A (ko) * 2004-06-30 2007-03-12 오노 야꾸힝 고교 가부시키가이샤 메니에르병의 예방 및/또는 치료제
US20070219272A1 (en) * 2006-02-06 2007-09-20 Johan Stjernschantz Novel method and compositions for treatment of tinnitus
KR20130097813A (ko) 2008-04-21 2013-09-03 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
AU2009246870B2 (en) 2008-05-14 2013-08-01 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of otic disorders
US8648119B2 (en) 2008-05-23 2014-02-11 Otonomy, Inc. Controlled release immunomodulator compositions and methods for the treatment of otic disorders
US8846770B2 (en) * 2008-06-18 2014-09-30 Otonomy, Inc. Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
WO2010011466A2 (en) 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8349353B2 (en) 2008-06-27 2013-01-08 Otonomy, Inc. Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
US8496957B2 (en) 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
AU2014200457B2 (en) * 2008-07-21 2016-07-28 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
JP5421366B2 (ja) 2008-07-21 2014-02-19 オトノミ―，インク． 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8399018B2 (en) 2008-07-21 2013-03-19 Otonomy, Inc. Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
JP2012506436A (ja) * 2008-10-22 2012-03-15 ハウス イアー インスティトゥート 代謝型グルタミン酸受容体の調節による内耳の疾病の処置および／または予防
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
MX2016002408A (es) 2013-08-27 2016-10-28 Otonomy Inc Metodos para el tratamiento de trastornos oticos pediatricos.
KR20190024983A (ko) 2016-06-29 2019-03-08 오토노미, 인코포레이티드 트리글리세라이드 귀 제제 및 이의 용도
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5176654B1 (en) 1990-12-07 1999-12-07 Simeon B Schreiber Method and apparatus for otologic administration of medicament
KR950000664A (ko) 1993-06-14 1995-01-03 우에노 도시오 신규한 13,14-디히드로-피지에프 2 베타(PGF2β) 및 이의 이소프로필 에스테르
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5421818A (en) 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
KR950032113A (ko) * 1994-03-22 1995-12-20 우에노 도시오 프로스타글란딘 에프 에스테르
US6045528A (en) * 1997-06-13 2000-04-04 Intraear, Inc. Inner ear fluid transfer and diagnostic system
EP1059926A2 (de) * 1997-12-18 2000-12-20 SCOTT, Nathan Earl Kombination, bestehend aus den prostaglandinen e2/f2-alpha, zur behandlung der impotenz und zur erhöhung der sexuelllen erregbarkeit
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
US6120484A (en) * 1999-02-17 2000-09-19 Silverstein; Herbert Otological implant for delivery of medicament and method of using same

Also Published As

Publication number Publication date
EP1351693B1 (de) 2010-06-09
HK1061975A1 (en) 2004-10-15
NZ526972A (en) 2005-02-25
CN1487832A (zh) 2004-04-07
WO2002056890A1 (en) 2002-07-25
EP1351693A1 (de) 2003-10-15
CA2434272C (en) 2011-03-08
US7498360B2 (en) 2009-03-03
PL362803A1 (en) 2004-11-02
BR0206568A (pt) 2004-01-27
AU2002219765B2 (en) 2005-10-27
US20040029970A1 (en) 2004-02-12
SE0100158D0 (sv) 2001-01-19
CA2434272A1 (en) 2002-07-25
MXPA03006439A (es) 2003-09-22
ATE470446T1 (de) 2010-06-15
CN1307998C (zh) 2007-04-04
JP4960931B2 (ja) 2012-06-27
JP2009019043A (ja) 2009-01-29
JP2004520361A (ja) 2004-07-08
JP4202135B2 (ja) 2008-12-24

Similar Documents

Publication Publication Date Title
DE60236639D1 (de) Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE69930259D1 (de) Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
CY1107780T1 (el) Μεθοδος για τη θεραπεια οφθαλμικων νεοαγγειακων ασθενειων
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
NO20050718L (no) Topikal behandling av hudsykdommer
DE602004017481D1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE60008753D1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
YU78701A (sh) Tretiranje neurotskih poremećaja
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
IT1318667B1 (it) Medicamento antinfiammatorio.
DE60127552D1 (de) Intrakorporelle medikamente zur hoch-energetischen phototherapeutischen behandlung von krankheiten
FR2794977B1 (fr) Utilisation de compositions contenant des formes solubles d'hla-g dans le traitement de pathologies inflammatoires de la peau, et leur procede d'obtention
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs